"The long-acting shot, given six times a year or every other month, is an alternative to taking daily pills to protect against the virus. Experts hope the cabotegravir (CAB-LA) injections will help meet the ambition of ending new HIV cases by 2030 in the UK. Meanwhile, early results for a different injection called lenacapavir suggest it may even be possible to move people on to an annual HIV prevention jab."
"Pills have been available for years and are still extremely effective at stopping HIV infections, but are not always easy for some to take. It can be hard to access, not practical, or feel embarrassing. For example, people might worry someone like parents or housemates could find their pills. Homelessness and domestic violence can make it difficult to take oral PrEP every day. An injection which lasts for months offers convenience and discretion."
Cabotegravir (CAB-LA), a long-acting HIV prevention injection, will be offered on the NHS in England and Wales, aligning policy with Scotland. The injection is administered six times a year or every other month as an alternative to daily oral PrEP pills. Early results for lenacapavir indicate the potential for an annual HIV prevention jab in the future. The injections aim to improve access and adherence for people who find daily pills difficult due to embarrassment, housing instability, or safety concerns. Cabotegravir should be used alongside safer sex practices, and the NHS has secured a discounted price from the manufacturer.
Read at www.bbc.com
Unable to calculate read time
Collection
[
|
...
]